Cleared Traditional

Supria True64 Whole-Body X-Ray CT System (K183291) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K183291 · Hitachi Healthcare Americas · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2019
Decision
67d
Days
Class 2
Risk

K183291 is an FDA 510(k) clearance for the Supria True64 Whole-Body X-Ray CT System. Classified as System, X-ray, Tomography, Computed (product code JAK), Class II - Special Controls.

Submitted by Hitachi Healthcare Americas (Twinsburg, US). The FDA issued a Cleared decision on February 1, 2019 after a review of 67 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1750 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hitachi Healthcare Americas devices

Submission Details

510(k) Number K183291 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 2018
Decision Date February 01, 2019
Days to Decision 67 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 107d · This submission: 67d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JAK System, X-ray, Tomography, Computed
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1750
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAK System, X-ray, Tomography, Computed

All 421
Devices cleared under the same product code (JAK) and FDA review panel - the closest regulatory comparables to K183291.
Bone VCAR (BVCAR)
K183204 · GE Medical Systems SCS · Apr 2019
NewTom 5G XL
K183448 · Cefla S.C. · Mar 2019
SnapShot Freeze 2
K183161 · Ge Medical Systems, LLC · Feb 2019
uCT 520, uCT 528
K183143 · Shangai United Imaging Healthcare Co., Ltd. · Jan 2019
Celesteion, PCA-9000A/3, V6.5
K181646 · Canon Medical Systems Corporation · Nov 2018
CURA 16
K173076 · Fmi Medical Systems, Inc. · Oct 2018